A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
KMT leader urges Taiwanese efforts, not Trump's, for cross-strait peace
10/08/2025 07:21 PM - Business
Taiwan Weeks 2025 to open Oct. 15 to promote asset hub plan
10/08/2025 07:07 PM - Society
Tropical Storm Nakri forms, unlikely to affect Taiwan
10/08/2025 05:57 PM - Science & Tech
Google launches Traditional Chinese version of AI Mode search
10/08/2025 05:30 PM - Society
Taiwan to ban raccoons, crocodiles and two families of snake as pets
10/08/2025 05:18 PM